6533b85dfe1ef96bd12bdffe
RESEARCH PRODUCT
Ocular surface disease during dupilumab treatment in patients with atopic dermatitis, is it possible to prevent it?
Elena CastelliSalvatrice CurialeGiuseppe PistoneRosario GurreriMaria Rita BongiornoGiovanna Tilottasubject
medicine.medical_specialtyInterleukin-13Ocular surface diseasebusiness.industryMEDLINEEczemaDermatologyAtopic dermatitismedicine.diseaseAntibodies Monoclonal HumanizedDupilumabDermatologyDermatitis Atopicdupilumab atopic dermatitis ocular surface diseaseInfectious DiseasesmedicineHumansIn patientbusinessyear | journal | country | edition | language |
---|---|---|---|---|
2020-02-13 | Journal of the European Academy of Dermatology and Venereology : JEADV |